Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TOBRAMYCIN
- Safety and Efficacy of Thermosensitive Hydroxybutyl Chitosan and 5-fluorouracil Assisted Endoscopic Dacryocystorhinostomy in the Treatment of Chronic Dacryocystitis
- A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis
- Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis
- Vancomycin and Tobramycin Powder Use in Acute Open Fractures
- A Second Trial of the Abbreviated Protocol Two-Stage Exchange
- Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- Antibiotic Loaded Cement After TKA
- Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial
- Preoperative Bevacizumab Injection in Primary Pterygium in Tunisian Patients
- Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients
- Imipenem, Cilastatin Sodium, and Relebactam Monohydrate for the Treatment of Cancer Patients With Febrile Neutropenia
- Tobramycin Injection to Prevent Infection in Open Fractures
- Acute Application of Antibiotic Powder in Open Fracture Wounds
- Hyperbaric Oxygen Treatment in Humans With Gram Positive Cocci Endocarditis
- Abbreviated Protocol for Two-Stage Exchange
- Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA
- Inhaled Tobramycin in BPD
- Intraarticular Antibiotic in TKA
- Antibiotic Bladder Instillations vs. Oral Suppression for the Treatment of Recurrent Urinary Tract Infections
- To Study Efficacy and Safety of Tobradex Eye Drop Suspension vs Tobramycin/Dexamethasone Ophthalmic Suspension
- Antibiotic Elution in Total Knee Arthroplasty
- Tobramycin Administered at the Beginning of Dialysis
- Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
- Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa
- Locally Applied Antibiotics for Infection Prophylaxis in Treatment of Open Fractures
- Impact of 0.1% and 0.2% Sodium Hyaluronate on Postoperative Discomfort Following Phacoemulsification Surgery
- Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis
- Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules
- DPI-Tobra-Kind Cyclops® in Children With Cystic Fibrosis
- A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis
- Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients
- Study for Antibiotic Impregnated Calcium Sulfate Beads as Prophylaxis for Surgical Site Infection
- The Use of Inhaled Aztreonam in Children With a Tracheostomy Tube and Pseudomonas
- Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic Fibrosis
- IV Colistin for Pulmonary Exacerbations: Improving Safety and Efficacy
- Tobramycin Delivered by Nebulized Sonic Aerosol for Chronic Rhinosinusitis Treatment of Cystic Fibrosis Patients
- Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Agents
- SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity
- A Bioequivalence Study to Compare the Pharmacokinetics (PK) Of Marketed Product TobraDex® To An Experimental Ophthalmic Sterile Ointment Containing Tobramycin And Dexamethasone In Aqueous Humor In Patients Undergoing Indicated Cataract Surgery
- Aztreonam Aerosol to Treat Cystic Fibrosis Nasal Disease
- Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection
- Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF)
- Inhaled Nebulized Tobramycin in Non-cystic Fibrosis Bronchiectasis
- Topical Irrigation Therapy for CRS
- Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified
- A Pharmacokinetic-pharmacodynamic Dose Comparison Study of 8 mg/kg of Inhaled or Parenteral Gentamicin in 12 Mechanically Ventilated Critically Ill Patients Treated for Ventilator-associated Pneumonia
- Besifloxacin in Bacterial Keratitis
- Antibiotic Nephrotoxicity in Adult Patients With Cystic Fibrosis
- Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia
- Observational Study in Cystic Fibrosis Patients Using TOBI® Podhaler™ or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs
- Addition of Tobramycin Inhalation in the Treatment of Ventilator Associated Pneumonia
- Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients
- Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study
- Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex
- Ecological Effects of Decolonisation Strategies in Intensive Care
- Pharmacokinetic and Pharmacoscintigraphic Comparison of TobrAir® 6.0 With TOBI® and TOBI® Podhaler™
- Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
- Bromfenac to Reduce Inflammation in Patients With Pseudoexfoliation Syndrome After Cataract Surgery
- Evaluation of Inhaled Antibiotics on Bacterial Diversity and Richness in the Cystic Fibrosis Lung
- Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection
- OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis
- Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis
- Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles
- Tobramycin Exposure From Active Calcium Sulfate Bone Graft Substitute
- Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI)
- Ext. Long-term Safety Study in CF Patients: Single Arm TIP
- Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis
- A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis
- Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF
- Tobramycin 300 mg Once-a-day (o.d.) Aerosol in Adults With Cystic Fibrosis
- Clinical Trials to Reduce the Risk of Antimicrobial Resistance
- Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis
- Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis
- Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis
- Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis
- Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus® /Pulmoaid® in Patients With Cystic Fibrosis
- Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections
- Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus®
- Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients
- Chalazion Conservative Treatment Trial
- Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis
- MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis
- Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.
- A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
- Ketorolac Plus Tobramycin/Dexamethasone Versus Tobramycin/Dexamethasone After Uneventful Phacoemulsification Surgery
- Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years
- Second Open Label Extension to Bridging Study CTBM100C2303
- Duration of Antibiotics in Infective Exacerbations of Cystic Fibrosis
- Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis
- Tobramycin-Dexamethasone Versus Tobramycin-Dexamethasone Plus Ketorolac After Phacoemulsification Surgery
- Open Label Extension to Bridging Study CTBM100C2303
- A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo
- Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation
- A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI®
- A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin
- Comparison of Antibiotics for Pseudomonas in Early CF
- Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection
- Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization
- Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa
- Effect of Pioglitazone on Inflammation in Cystic Fibrosis
- Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis
- Tobramycin Tear Concentrations
- Topical Antibiotic Use In Chronic Rhinosinusitis A Double-Blinded, Randomized, Placebo Controlled Study
- Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin
- Self-dispersing Liquids as Aerosol Drug Carriers
- TOBRADEX Ophthalmic Suspension Versus Tobramycin 0.3%/Dexamethasone 0.05% Ophthalmic Suspension
- Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis
- Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis
- Zylet vs TobraDex in Blepharokeratoconjunctivitis
- Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic Study
- Pediatric Zylet Safety and Efficacy Study
- Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy Study
- Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic Fibrosis
- Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis
- Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis
- Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis
- The Tobramycin Study
- A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte
- Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects
- Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)
- Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
- Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis
- A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis
- Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis
Clinical trials list
click for details